Clough Capital Partners’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-37,681
Closed -$7.11M 126
2022
Q1
$7.11M Hold
37,681
0.54% 60
2021
Q4
$9.2M Sell
37,681
-1,314
-3% -$288K 0.61% 49
2021
Q3
$7.57M Sell
38,995
-33,670
-46% -$6.79M 0.46% 60
2021
Q2
$13.5M Sell
72,665
-46,340
-39% -$8.05M 0.74% 56
2021
Q1
$18.7M Buy
119,005
+76,830
+182% +$12.2M 0.84% 47
2020
Q4
$6.98M Hold
42,175
0.5% 66
2020
Q3
$6.97M Buy
42,175
+7,025
+20% +$1.08M 0.5% 60
2020
Q2
$4.82M Sell
35,150
-14,660
-29% -$1.91M 0.47% 71
2020
Q1
$5.86M Sell
49,810
-38,380
-44% -$5.05M 0.58% 48
2019
Q4
$11.7M Sell
88,190
-400
-0.5% -$49.7K 1% 41
2019
Q3
$11M Sell
88,590
-39,600
-31% -$4.78M 0.91% 32
2019
Q2
$14.5M Buy
128,190
+51,990
+68% +$5.44M 1.43% 22
2019
Q1
$7.67M Buy
76,200
+26,730
+54% +$2.43M 0.67% 52
2018
Q4
$4.23M Buy
+49,470
New +$4.46M 0.5% 63

Other funds holding ZTS

Clough Capital Partners's ZTS Position: Q2 2022 in Review

Clough Capital Partners sold out of Zoetis (ZTS) in Q2 2022, closing a stake of 37,681 shares — an estimated $7.11M sold.

Clough Capital Partners first reported a position in ZTS in Q4 2018 and held it in 14 quarters. The position peaked at $18.7M in Q1 2021. 1,563 funds tracked by Wall St. Rank hold ZTS as of Q2 2022.

  • Clough Capital Partners reported no remaining Zoetis position as of Q2 2022 after selling out during the quarter.
  • Clough Capital Partners sold 37,681 Zoetis shares in Q2 2022, an estimated $7.11M.
  • Clough Capital Partners first reported a position in Zoetis in Q4 2018 and held it in 14 quarters.
  • Clough Capital Partners's Zoetis position peaked at $18.7M in Q1 2021.
  • 1,563 funds tracked by Wall St. Rank held Zoetis as of Q2 2022.

Based on Clough Capital Partners's 13F filing for Q2 2022, filed 16 Aug 2022.